Skip to main content
Clinical Trials/NCT00591305
NCT00591305
Terminated
Not Applicable

Voice Preserving Therapy of Laryngeal Papilloma In Children

Boston University1 site in 1 country1 target enrollmentSeptember 2007
ConditionsPapilloma

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Papilloma
Sponsor
Boston University
Enrollment
1
Locations
1
Primary Endpoint
Number of Cases With Recurrence of Laryngeal Papilloma in 5 Months
Status
Terminated
Last Updated
8 years ago

Overview

Brief Summary

This study will determine efficacy of a new and combined treatment of laryngeal recurrent respiratory papillomatosis (RRP), by using a 585 nm pulsed dye laser (PDL) and a dietary supplement, diindolylmethane (DIM). We will compare this new treatment with PDL-only, in a total of 30 children (15 of each treatment), to determine whether this combined treatment would be effective and safe in preventing the RRP recurrence. This is the first study to combine PDL technique with DIM, to develop a new, voice-preserving and long-term effective method of managing laryngeal RRP in children.

Detailed Description

Previous studies have demonstrated that PDL can be used to remove lesions on the vocal cords and elsewhere in the throat causing less damage to surface tissues than other commonly used lasers. In our proposed clinical study, we seek to compare treatment efficacy for RRP by combining PDL with DIM, versus PDL-only treatment, in a total of 30 children with laryngeal papilloma. We will determine whether this combined treatment would be effective and safe in preventing or delaying the RRP recurrence while preserving voice quality. 30 children will be divided randomly into two treatment groups, 15 in each. The experimental group will receive one-time PDL treatment, followed by 3-month oral administration of DIM and an additional 12 months with no treatment. The other group will be treated with PDL-only, as a control, and take a placebo pill for 3 months. All of the patients will be followed for a total of 15 months. We will compare lesion recurrence and laboratory tests between the two groups, to determine efficacy and safety of the new treatment. This is the first study to combine new PDL laser technique with DIM, to develop a new, voice-preserving and long-term effective method of managing laryngeal RRP in children.

Registry
clinicaltrials.gov
Start Date
September 2007
End Date
October 2011
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Zhi Wang

Professor and Director

Boston University

Eligibility Criteria

Inclusion Criteria

  • 10 to 21 years of age
  • laryngeal papillomas requiring surgical treatment
  • willingness to participate in the study
  • a signed informed consent form by guardian or parent

Exclusion Criteria

  • age less than 10 year old, or older than 21 year
  • guardian or parent does not understand or can not sign the consent form
  • malignant diseases such as laryngeal cancer
  • history of being hypersensitive to cabbage or other cruciferous vegetables

Outcomes

Primary Outcomes

Number of Cases With Recurrence of Laryngeal Papilloma in 5 Months

Time Frame: Recurrence of pailloma at 5 months

vocal lesion size and area after 5 month with surgery visible lesion found in \>50% of the treated tissue area, after surgery

Secondary Outcomes

  • Estradiol Level in Blood Pre Treatment(Before treatment at baseline)
  • Estradiol Level in Blood Post Treatment(5 month)

Study Sites (1)

Loading locations...

Similar Trials